Xenon Pharmaceuticals Inc (XENE)
US$ 35.852.37%
Price Chart
Key Statistics
Market Cap
$ 2.68B
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
1.16M
52W High
$ 46.00
52W Low
$ 26.74
Dividend Yield
0.00%
Beta
1.22
Technicals
50-Day MA
35.0063
200-Day MA
39.1999
52 Week High
46
52 Week Low
26.74
About XENE
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric di.
Employees
316
Headquarters
Burnaby, BC
CEO
Ms. Andrea DiFabio J.D.
Latest News
Xenon Pharmaceuticals (XENE) Price Target Adjusted by Analyst | - GuruFocus
1 hour ago • Google News
XENON PHARMACEUTICALS Earnings Results: $XENE Reports Quarterly Earnings - Nasdaq
16 hours ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg